| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d3b6e03a92d64f0e4893a8b297f7647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bdfd6e8d4134430cb7a0e01863a7322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53e211d36ea18a28b99b1bc957d36990
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebf83fe0eff7116f9b464447613a6a7b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88 |
| filingDate |
2001-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae1a6c2eae61fd91b33ca8e0241592c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ef8f312ba1f16a36dbe48eaaac35c24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f8cdcf83bbc9af4b2e14ec06839221 |
| publicationDate |
2002-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0220052-A1 |
| titleOfInvention |
Use of lipopeptides for immunotherapy of hiv-positive subjects |
| abstract |
The invention concerns the use of lipopeptides for preparing a vaccine for controlling viral rebound in HIV-positive subjects undergoing anti-retroviral therapy exhibiting a viral load of not more than 10000 copies per ml of plasma and a rate of CD4+ not less than 300 cells per mm<3>, wherein the lipopeptides consist of a peptide chain of 7 to 100 amino acids comprising at least a CTL epitope of a HIV protein, covalently bound to a lipid chain comprising 8 to 20 carbon atoms. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03092479-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03092479-A3 |
| priorityDate |
2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |